Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Assets (2020 - 2025)

Revolution Medicines (RVMD) has 6 years of Return on Assets data on record, last reported at 0.49% in Q4 2025.

  • For Q4 2025, Return on Assets fell 21.0% year-over-year to 0.49%; the TTM value through Dec 2025 reached 0.49%, down 21.0%, while the annual FY2025 figure was 0.46%, 20.0% down from the prior year.
  • Return on Assets reached 0.49% in Q4 2025 per RVMD's latest filing, down from 0.41% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.18% in Q2 2021 and bottomed at 0.49% in Q4 2025.
  • Average Return on Assets over 5 years is 0.3%, with a median of 0.29% recorded in 2023.
  • Peak YoY movement for Return on Assets: rose 6bps in 2023, then fell -21bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.25% in 2021, then dropped by -20bps to 0.3% in 2022, then rose by 6bps to 0.29% in 2023, then grew by 3bps to 0.28% in 2024, then plummeted by -77bps to 0.49% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.49% in Q4 2025, 0.41% in Q3 2025, and 0.34% in Q2 2025.